Healthy outlook on life!

MEDIPAL is a modern, high-performance distribution company. It is amongst Top 10 pharmaceutical leading suppliers.

Learn more

TOP 10

ranking among

>30 years

of successful operation

16 offices

and representative offices

> 250

partners in the pharmaceutical industry
  • Mission
  • Corporate Values
  • History
  • Social Responsibility
  • Business Ethics

Draw on experience and knowledge to be the best at everything and stay on target. To unite and inspire a team of like-minded people constantly moving forward. To develop our success by acting responsibly, innovating, and improving the quality of life and the health of people.

Corporate Values

Everything we do is based on the corporate values that we defined for ourselves as a priority at the very beginning of our activity: responsibility, development, humanity, success.


For more than 25 years MEDIPAL has been a successful company demonstrating steady growth, social responsibility and confident development prospects.

Social Responsibility

Charitable activities are an integral part of the company’s overall strategy. For many years we have been active participants in various social programs and initiatives.

Business Ethics

Corporate reputation is one of the keys to business success. We are convinced that in addition to complying with all laws and regulations, it is important to act in accordance with the highest ethical and moral standards.

Focus Areas
Comprehensive provision of the healthcare system with innovative medicines
Orphan Diseases
Orphan Diseases
Hemostasis Disorders
Hemostasis Disorders
All areas
Happy Medical Worker's Day!
We wish you good health, patience, strength and energy.
Happy the 8th of March!
Congratulations on International Women's Day! We wish you inspiration, creative success, good health, joy, and sincere smiles. May you every day be filled with happiness, achievements, and new beginnings.
Merry Christmas

We wish you a Merry Christmas and a Happy New Year.

May the coming year be filled with a lot of wins and happiness, not just in deals but also in life.

MEDIPAL-ONCO — partner of the XIV All-Russian Congress of Patients
In 2023, MEDIPAL-ONCO become a partner of the All-Russian Congress of Patients, which is held from November 22 to 26.
MEDIPAL discussed possible options for cooperation with the Ambassador of Uruguay
On November 21, a meeting of enterprisers of «Delovaya Rossiya» was held with the Ambassador of Uruguay to Russia Daniel Ruben Castillos Gomez. The possibilities of expanding trade and investment cooperation between the two countries were discussed.
MEDIPAL took part in the discussion of the prospects of investment cooperation with Latin American countries
On November 13, the Russian Chamber of Commerce and Industry hosted a round table «New Horizons of Investment Cooperation in Modern Conditions»
MEDIPAL at the XV Congress of Russian Surgeons
MEDIPAL Group of Companies acted as a strategic partner of the XV Congress of Surgeons of Russia, which was held on October 24-26 in Moscow at the World Trade Center.
Congratulations on Medical Worker Day!
We are grateful for your patience, professionalism and dedication to your profession.
MEDIPAL organized a holiday for little patients of the NII NDHiT
On June 2, 2023, MEDIPAL Group, together with the Children's Doctor Roshal Foundation, organized a scientific event for little patients.
MEDIPAL took part in the conference "Modern possibilities of therapy of malignant neoplasms"
On April 22, the conference "Modern possibilities of therapy of malignant neoplasms" was held in Moscow
MEDIPAL-ONKO: Clearly Structured Work
Moscow Tenders (the official publication of the Mayor and Government of Moscow) published an article about the activities, plans and objectives of MEDIPAL-ONKO.
MEDIPAL-ONKO: Healthy Outlook on Life!
INOPharma magazine (published under the auspices of Delovaya Stolitsa) published an article about the activities, plans, prospects and objectives of MEDIPAL-ONKO.
MEDIPAL-ONKO LLC: Continuing to Move Forward
Moscow Tenders (the official publication of the Mayor and Government of Moscow) published an article about the activities, plans, prospects and objectives of MEDIPAL-ONKO.
You can't say «we» when you're standing on the sidelines
Moscow Tenders magazine published an interview with Sofia Perozhak, Head of the Strategic Development Department of MEDIPAL-ONKO.
MEDIPAL-ONKO LLC: on the Change Wave
Moscow Tenders (the official publication of the mayor and the government of Moscow) published an interview with Vladislava Torshina, Deputy Commercial Director of MEDIPAL-ONKO LLC.
Main Priority is the Supply of High Quality Medicinal Products
Moscow Tenders (the official publication of the Mayor and Government of Moscow) published an interview with Alexei Nemtsev, Commercial Director of MEDIPAL-ONKO LLC.
The resident of the «Technopolis Moscow» delivered more than three million medical products to the capital
According to the terms of the contract, the investor undertook to localize production in Moscow, and the city — to purchase its products for eight years.
According to the survey, more than half of Russians have never heard of orphan diseases
Most Russians - 65% - have never heard of orphan (rare) diseases, a study by the NAFI Analytical Center and the «Ludi-Mayaki» Charity Foundation showed.
Parliamentarians adopted in the second reading a bill on ensuring the availability of medical care and medicines to orphan patients
The State Duma adopted in the second reading a bill aimed at ensuring the availability of medical care and medicines for children and adults suffering from rare (orphan) diseases.
The capital's authorities have launched a remote prescription service for cancer patients
In Moscow, a telemedicine service has been introduced into the work of all outpatient cancer care centers, with it's help doctors can remotely extend previously written electronic prescriptions.
Resident Company of Technopolis Moscow Provided Benefit Recipients with more than 800,000 medical devices since the beginning of the year

Since the beginning of 2022, Gemamed, a resident company of the Technopolis Moscow Special Economic Zone (SEZ), has supplied more than 810,000 medical devices for ostomy patients, who receive these goods from the city free of charge, as part of an offset agreement. This was reported by the press service of the Complex for Economic Policy and Property and Land Relations of the capital.

Members of the Association of Ostomy Patients "ASTOM" visited the "GemaTech” production complex

The meeting was very productive, eventful, and informative. The company guided the “ASTOM” representatives through the complete technological chain of production — from the beginning of the assembly of products on a modern robotic line to the release of products in finished packaging.

Modern means of rehabilitation of ostomy patients: from idea to moder Russian production

The journal “ASTOM: Guide to Active Life” published an article on GemaTech, a company involved in the production of stoma care products.

GEMATECH as a part of the RIA NOVOSTI special project on public-private partnership

GemaTech took part in the RIA Novosti special project on public-private partnership in the Offset Agreement section.

S. Sobyanin on import substitution support measures

Sergey Sobyanin held a meeting with representatives of major pharmaceutical companies where they discussed the development of the industry and import substitution in conditions of external sanctions pressure.

Rules for import and export of clinical research biomaterials

The government has approved the rules for the import into and export from the Russian Federation of biomaterials obtained during clinical trials of medicines for human use. They will come into force on September 1 and will be valid until September 1, 2028; a corresponding decree of the Russian government has been published on the official Internet portal of legal information.



Our success is determined by our team — a team of caring people who share common values

Many years ago we chose health care as our mission and over the years of our development we have become a large professional company, earned a reputation of a reliable partner and gained a leading position in the industry. Today we are looking into the future with confidence.


Our partners include more than 250 leading Russian and foreign manufacturers of medicines and medical products.